As 5-HT2 receptor antagonists are effective in treating hallucinations among schizophrenic patients, it has been previously supposed that risperidone would be efficacious in treating HPPD (18, 30). This evidence concerns the gene HTR2A and hypertelorism-preauricular sinus-punctual pits-deafness syndrome.